Table 3.

Comparison of patients who had improvement of their HbA1c between Visit A and Visit B

	Improvement in HbA1c (n = 269)	No improvement in HbA1c (n = 235)	P‐value
Age ± SD (years)	58.9 ± 15.7	60.1 ± 16.6	0.423
Type 2 diabetes, n (%)	220 (81.8)	192 (81.7)	0.981
Requirement of insulin therapy, n (%)	210 (78.4)	174 (74.0)	0.257
Known cardiovascular disease, n (%)	80 (29.9)	84 (35.7)	0.160
Need for interpreters, n (%)	64 (23.8)	63 (26.8)	0.436
Anglo‐European background, n (%)	133 (49.4)	126 (53.6)	0.351
BGL records available to clinicians, n (%)	75 (27.9)	42 (17.9)	0.008

BGL, blood glucose level.